UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051727
Receipt number R000059037
Scientific Title Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron
Date of disclosure of the study information 2023/07/27
Last modified on 2023/07/27 16:55:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of genes involved in individual differences in ondansetron sensitivity

Acronym

Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron

Scientific Title

Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron

Scientific Title:Acronym

Elucidation of gene polymorphisms that contribute to nausea and vomiting after administration of ondansetron

Region

Japan


Condition

Condition

Patients undergoing orthognathic surgery

Classification by specialty

Oral surgery

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

We will analyze the genes that cause PONV after administration of ondansetron-dexamethasone.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Postoperative nausea attitude,Frequency of vomiting (2 hours later, 24 hours later)

Key secondary outcomes

Whether to use rescue anti-emetics (metoclopramide)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

Eligible patients meet the criteria of the American Society of Anesthesiologists(ASA) physical status of I-II.

Key exclusion criteria

Eligible patients meet the criteria of the American Society of Anesthesiologists(ASA) physical status of 3-5.
Patients without consent.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kyotaro
Middle name
Last name Koshika

Organization

Tokyo Dental College

Division name

Dental Anesthesiology

Zip code

101-0061

Address

2-9-18 Misakicho,Chiyodaku,Tokyo-to 101-0061 Japan

TEL

03-6380-9001

Email

koshikakyotarou@tdc.ac.jp


Public contact

Name of contact person

1st name Yuna
Middle name
Last name Kang

Organization

Tokyo Dental College

Division name

Dental Anesthesiology

Zip code

101-0061

Address

2-9-18 Misakicho,Chiyodaku,Tokyo-to 101-0061 Japan

TEL

03-6380-9001

Homepage URL


Email

yunakang@tdc.ac.jp


Sponsor or person

Institute

Tokyo Dental College

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Dental College Ethics Review Board

Address

2-9-18 Misakicho,Chiyodaku,Tokyo-to 101-0061 Japan

Tel

03-6380-9001

Email

drinri@tdc.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 05 Month 02 Day

Date of IRB

2023 Year 05 Month 02 Day

Anticipated trial start date

2023 Year 05 Month 03 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Administer dexamethasone before surgery and ondansetron at the end of surgery.


Management information

Registered date

2023 Year 07 Month 27 Day

Last modified on

2023 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059037


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name